Concepedia

Publication | Open Access

Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy

91

Citations

19

References

2012

Year

References

YearCitations

1981

7.8K

2002

4.9K

2002

3.7K

2011

1.3K

2002

890

2000

594

2008

564

2011

556

2011

471

2007

461

Page 1